Alumis (ALMS) Current Assets (2023 - 2026)
Alumis (ALMS) posted quarterly Current Assets of $318.2 million for Q4 2025, up 3.93% year-over-year from $306.2 million in Q4 2024, and down 19.08% quarter-over-quarter from $393.3 million in Q3 2025.
Alumis (ALMS) Current Assets (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported Current Assets for 3 consecutive years, with $318.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets rose 3.93% year-over-year to $318.2 million; the TTM figure through Dec 2025 stood at $318.2 million (up 3.93% YoY), while the FY2025 annual figure was $318.2 million, up 3.93% from the prior year.
- Current Assets eased to $318.2 million in Q4 2025 per ALMS's latest filing, from $393.3 million in the prior quarter.
- Across five years, Current Assets topped out at $517.6 million in Q2 2025 and bottomed at $53.4 million in Q4 2023.
- Historically, Current Assets has averaged $302.0 million across 3 years, with a median of $312.2 million in 2024.
- Annual changes were most pronounced in 2024 — Current Assets surged 473.85% — and 2025, when it grew 3.93%.
- Alumis' Current Assets stood at $53.4 million in 2023, then soared by 473.85% to $306.2 million in 2024, then climbed by 3.93% to $318.2 million in 2025.
- Business Quant data shows ALMS's Current Assets at $318.2 million in Q4 2025, $393.3 million in Q3 2025, and $517.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Alumis | 3.25 Bn | 2.75 Bn | - | 514.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 514.08 Mn |
| Dec 31, 2025 | 318.23 Mn |
| Sep 30, 2025 | 393.29 Mn |
| Jun 30, 2025 | 517.56 Mn |
| Mar 31, 2025 | 225.53 Mn |
| Dec 31, 2024 | 306.19 Mn |
| Sep 30, 2024 | 377.35 Mn |
| Jun 30, 2024 | 224.86 Mn |
| Dec 31, 2023 | 53.36 Mn |